DX D Biotech T 5 Bull 2X ETFTBXUETF
13F holders, Q4 2025 (December 31)3holders +2
2new positions
0sold out
$31.07avg. 13F price*
At the end of Q4 2025, 3 institutions reported holding DX D Biotech T 5 Bull 2X ETF (TBXU) in their 13F filings, up 2 from Q3 2025. 2 opened new positions and 0 sold out. The largest holders were Bank of America Corp. ($777K), Goldman Sachs Group Inc. ($777K) and GTS Securities LLC ($724K).
- Company
- DX D Biotech T 5 Bull 2X ETF
- Filed as
- DIREXION SHS ETF TR (Q4 2025)
- CUSIP
- 25461H101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $1.5M |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 48,310 shares bought, net +48,310 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Bank of America Corp. | 0.00% | New | 25,000 | $777K |
| Goldman Sachs Group Inc. | 0.00% | No change | 25,000 | $777K |
| GTS Securities LLC | 0.02% | New | 23,310 | $724K |
"% of holder's portfolio" is TBXU's weight in each manager's 13F, not the share of DX D Biotech T 5 Bull 2X ETF the manager owns.